Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
14.00
-0.20 (-1.41%)
At close: Apr 28, 2026
-2.10%
Market Cap 1.45B
Revenue (ttm) 431.04M
Net Income (ttm) 42.40M
Shares Out 103.81M
EPS (ttm) 0.41
PE Ratio 34.13
Forward PE n/a
Dividend 0.11 (0.77%)
Ex-Dividend Date Dec 17, 2025
Volume 279,822
Average Volume 1,033,321
Open 14.20
Previous Close 14.20
Day's Range 13.90 - 14.40
52-Week Range 11.10 - 18.50
Beta 0.23
RSI 44.59
Earnings Date Apr 29, 2026

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 313
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SILCOPHL
Full Company Profile

Financial Performance

In fiscal year 2025, Silco Pharmaceuticals's revenue was 431.54 million, an increase of 5.23% compared to the previous year's 410.10 million. Earnings were 42.65 million, a decrease of -7.04%.

Financial Statements

News

There is no news available yet.